U.S Physical Therapy Debt to Equity Ratio 2010-2023 | USPH

Current and historical debt to equity ratio values for U.S Physical Therapy (USPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. U.S Physical Therapy debt/equity for the three months ending December 31, 2023 was 0.29.
U.S Physical Therapy Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.52B $0.48B 1.09
2023-09-30 $0.52B $0.49B 1.05
2023-06-30 $0.51B $0.49B 1.04
2023-03-31 $0.55B $0.32B 1.72
2022-12-31 $0.54B $0.32B 1.71
2022-09-30 $0.48B $0.32B 1.51
2022-06-30 $0.49B $0.31B 1.58
2022-03-31 $0.46B $0.30B 1.53
2021-12-31 $0.45B $0.30B 1.52
2021-09-30 $0.34B $0.29B 1.17
2021-06-30 $0.34B $0.29B 1.19
2021-03-31 $0.32B $0.28B 1.16
2020-12-31 $0.32B $0.28B 1.14
2020-09-30 $0.31B $0.27B 1.16
2020-06-30 $0.33B $0.26B 1.28
2020-03-31 $0.40B $0.24B 1.66
2019-12-31 $0.32B $0.24B 1.32
2019-09-30 $0.33B $0.24B 1.38
2019-06-30 $0.33B $0.23B 1.41
2019-03-31 $0.30B $0.22B 1.37
2018-12-31 $0.23B $0.22B 1.04
2018-09-30 $0.24B $0.21B 1.14
2018-06-30 $0.23B $0.21B 1.07
2018-03-31 $0.21B $0.21B 1.00
2017-12-31 $0.21B $0.21B 1.03
2017-09-30 $0.21B $0.20B 1.06
2017-06-30 $0.22B $0.20B 1.13
2017-03-31 $0.20B $0.19B 1.01
2016-12-31 $0.16B $0.19B 0.86
2016-09-30 $0.09B $0.22B 0.42
2016-06-30 $0.10B $0.21B 0.46
2016-03-31 $0.10B $0.21B 0.49
2015-12-31 $0.13B $0.17B 0.76
2015-09-30 $0.09B $0.19B 0.48
2015-06-30 $0.09B $0.18B 0.47
2015-03-31 $0.08B $0.18B 0.46
2014-12-31 $0.08B $0.17B 0.46
2014-09-30 $0.09B $0.16B 0.52
2014-06-30 $0.08B $0.16B 0.47
2014-03-31 $0.07B $0.15B 0.48
2013-12-31 $0.07B $0.15B 0.48
2013-09-30 $0.03B $0.15B 0.23
2013-06-30 $0.04B $0.15B 0.24
2013-03-31 $0.04B $0.14B 0.27
2012-12-31 $0.04B $0.14B 0.28
2012-09-30 $0.03B $0.14B 0.25
2012-06-30 $0.04B $0.13B 0.29
2012-03-31 $0.04B $0.13B 0.31
2011-12-31 $0.04B $0.12B 0.34
2011-09-30 $0.04B $0.12B 0.34
2011-06-30 $0.03B $0.12B 0.28
2011-03-31 $0.03B $0.11B 0.30
2010-12-31 $0.02B $0.12B 0.21
2010-09-30 $0.02B $0.11B 0.19
2010-06-30 $0.02B $0.10B 0.20
2010-03-31 $0.03B $0.10B 0.30
2009-12-31 $0.02B $0.09B 0.21
2009-09-30 $0.02B $0.09B 0.24
2009-06-30 $0.03B $0.09B 0.31
2009-03-31 $0.03B $0.09B 0.36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.558B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.181B 15.69
DaVita (DVA) United States $11.744B 15.98
Chemed (CHE) United States $9.320B 29.33
Encompass Health (EHC) United States $8.258B 22.65
Elanco Animal Health (ELAN) United States $6.651B 15.12
Option Care Health (OPCH) United States $5.317B 20.12
RadNet (RDNT) United States $3.344B 97.66
Amedisys (AMED) United States $2.978B 21.25
LifeStance Health (LFST) United States $2.326B 0.00
Astrana Health (ASTH) United States $2.077B 26.21
Addus HomeCare (ADUS) United States $1.538B 23.57
Pennant (PNTG) United States $0.643B 37.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.330B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00